Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy

Scand J Rheumatol. 2019 Jul;48(4):342-343. doi: 10.1080/03009742.2018.1533035. Epub 2018 Dec 10.

K B Bukan^{1

2}, A Nardo-Marino¹, C Hagdrup³, M Boennelycke⁴, M F Breinholdt⁴, C Schöllkopf¹, H V Nielsen⁵, D El Fassi^{1

6}

¹ a Department of Haematology , Herlev and Gentofte University Hospital , Herlev , Denmark.
² b Department of Nephrology , Herlev and Gentofte University Hospital , Herlev , Denmark.
³ c Department of Anesthesiology , Herlev and Gentofte University Hospital , Herlev , Denmark.
⁴ d Department of Pathology , Herlev and Gentofte University Hospital , Herlev , Denmark.
⁵ e Department of Bacteria, Parasites and Fungi , Statens Serum Institut , Copenhagen , Denmark.
⁶ f Department of Rheumatology , Institute for Inflammation Research , Copenhagen , Denmark.

No abstract available

Publication types